Dr. Min-Jun Baek earned his doctoral degree in pharmaceutical sciences, specializing in drug delivery systems. His research primarily focused on developing renal-clearable cyclodextrin nanocarriers for selective delivery of anticancer agents to tumors. Following the completion of his Ph.D., he continued his work by concentrating on engineering renal-clearable nanocarriers and near-infrared fluorophores for image-guided interventions in anticancer therapy.

In March 2024, he joined the Bioengineering & Nanomedicine Program (BENMD) at Harvard Medical School and Massachusetts General Hospital. In the BENMD program, his research is centered on nano-bio interactions and tailoring the in vivo fate of polymeric nanomaterials, with a focus on their application in disease diagnosis and treatment.